☰

Erica J. Young, Ph.D. - Publications

Affiliations: 
University of Virginia, Charlottesville, VA 
Area:
Learning and Memory
Tree Info Grants Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Young EJ, Lin H, Kamenecka TM, Rumbaugh G, Miller CA. Methamphetamine learning induces persistent and selective nonmuscle myosin II-dependent spine motility in the basolateral amygdala. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32066582 DOI: 10.1523/Jneurosci.2182-19.2020  0.486
2018 Briggs SB, Hafenbreidel M, Young EJ, Rumbaugh G, Miller CA. The role of nonmuscle myosin II in polydrug memories and memory reconsolidation. Learning & Memory (Cold Spring Harbor, N.Y.). 25: 391-398. PMID 30115760 DOI: 10.1101/Lm.046763.117  0.487
2017 Briggs SB, Blouin AM, Young EJ, Rumbaugh G, Miller CA. Memory disrupting effects of nonmuscle myosin II inhibition depend on the class of abused drug and brain region. Learning & Memory (Cold Spring Harbor, N.Y.). 24: 70-75. PMID 28096495 DOI: 10.1101/Lm.043976.116  0.479
2017 Young EJ, Briggs SB, Rumbaugh G, Miller CA. Nonmuscle myosin II inhibition disrupts methamphetamine-associated memory in females and adolescents. Neurobiology of Learning and Memory. PMID 28082169 DOI: 10.1016/J.Nlm.2017.01.001  0.463
2016 Young EJ, Blouin AM, Briggs SB, Sillivan SE, Lin L, Cameron MD, Rumbaugh G, Miller CA. Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use. Molecular Psychiatry. 21: 615-23. PMID 26239291 DOI: 10.1038/Mp.2015.103  0.483
2015 Young EJ, Briggs SB, Miller CA. The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use. Cns & Neurological Disorders Drug Targets. 14: 731-7. PMID 26022262 DOI: 10.2174/1871527314666150529145531  0.438
2014 Aguilar-Valles A, Vaissière T, Griggs EM, Mikaelsson MA, Takács IF, Young EJ, Rumbaugh G, Miller CA. Methamphetamine-associated memory is regulated by a writer and an eraser of permissive histone methylation. Biological Psychiatry. 76: 57-65. PMID 24183790 DOI: 10.1016/J.Biopsych.2013.09.014  0.415
2014 Young EJ, Aceti M, Griggs EM, Fuchs RA, Zigmond Z, Rumbaugh G, Miller CA. Selective, retrieval-independent disruption of methamphetamine-associated memory by actin depolymerization. Biological Psychiatry. 75: 96-104. PMID 24012327 DOI: 10.1016/J.Biopsych.2013.07.036  0.453
2013 Young EJ, Williams CL. Differential activation of amygdala Arc expression by positive and negatively valenced emotional learning conditions. Frontiers in Behavioral Neuroscience. 7: 191. PMID 24367308 DOI: 10.3389/Fnbeh.2013.00191  0.505
2013 Griggs EM, Young EJ, Rumbaugh G, Miller CA. MicroRNA-182 regulates amygdala-dependent memory formation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 1734-40. PMID 23345246 DOI: 10.1523/Jneurosci.2873-12.2013  0.417
2012 Gavin CF, Rubio MD, Young E, Miller C, Rumbaugh G. Myosin II motor activity in the lateral amygdala is required for fear memory consolidation. Learning & Memory (Cold Spring Harbor, N.Y.). 19: 9-14. PMID 22174310 DOI: 10.1101/Lm.024042.111  0.454
2010 Young EJ, Williams CL. Valence dependent asymmetric release of norepinephrine in the basolateral amygdala. Behavioral Neuroscience. 124: 633-44. PMID 20939663 DOI: 10.1037/A0020885  0.469
Show low-probability matches.